News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,503 Results
Type
Article (973)
Company Profile (1)
Press Release (20529)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (11447)
Career Advice (32)
Deals (1370)
Drug Delivery (2)
Drug Development (1491)
Employer Resources (1)
FDA (334)
Job Trends (514)
News (13944)
Policy (520)
Tag
Academia (16)
Allergies (1)
Alliances (608)
ALS (2)
Alzheimer's disease (25)
Antibody-drug conjugate (ADC) (8)
Approvals (346)
Artificial intelligence (7)
Autoimmune disease (3)
Automation (1)
Bankruptcy (2)
Best Places to Work (452)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (1)
Bladder cancer (8)
Brain cancer (1)
Breast cancer (11)
Cancer (100)
Cardiovascular disease (16)
Career advice (25)
Career pathing (2)
CAR-T (3)
Cell therapy (10)
Cervical cancer (1)
Clinical research (1381)
Collaboration (16)
Compensation (14)
COVID-19 (34)
CRISPR (2)
C-suite (6)
Cystic fibrosis (2)
Data (142)
Depression (4)
Diabetes (10)
Diagnostics (189)
Digital health (1)
Drug discovery (2)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (11342)
Editorial (2)
Employer resources (1)
Events (1823)
Executive appointments (3)
FDA (496)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (10)
Gene editing (2)
Gene therapy (8)
GLP-1 (23)
Government (44)
Guidances (128)
Healthcare (497)
Huntington's disease (2)
IgA nephropathy (1)
Immunology and inflammation (11)
Immuno-oncology (2)
Infectious disease (40)
Inflammatory bowel disease (1)
Influenza (1)
Intellectual property (2)
Interviews (3)
IPO (1084)
Job creations (93)
Job search strategy (20)
JPM (8)
Kidney cancer (1)
Labor market (3)
Layoffs (8)
Leadership (1)
Legal (125)
Lung cancer (16)
Lymphoma (14)
Management (1)
Manufacturing (7)
MASH (5)
Medical device (494)
Medtech (501)
Mergers & acquisitions (296)
Metabolic disorders (30)
Multiple sclerosis (2)
NASH (1)
Neurodegenerative disease (3)
Neuropsychiatric disorders (5)
Neuroscience (47)
Neurotech (1)
NextGen: Class of 2026 (94)
Non-profit (29)
Obesity (13)
Opinion (6)
Ovarian cancer (1)
Pain (1)
Pancreatic cancer (2)
Parkinson's disease (2)
Patents (8)
Patient recruitment (2)
People (577)
Pharmacy benefit managers (1)
Phase 1 (268)
Phase 2 (569)
Phase 3 (595)
Pipeline (499)
Policy (2)
Postmarket research (75)
Preclinical (96)
Press Release (1)
Prostate cancer (9)
Psychedelics (1)
Radiopharmaceuticals (5)
Rare diseases (13)
Real estate (67)
Regulatory (395)
Reports (7)
Research institute (18)
Resumes & cover letters (5)
RSV (3)
Schizophrenia (5)
Sickle cell disease (1)
Special edition (3)
Spinal muscular atrophy (4)
Startups (35)
Supply chain (3)
The Weekly (1)
Vaccines (12)
Venture capital (6)
Weight loss (6)
Women's health (3)
Worklife (1)
Date
Last 7 days (20)
Last 30 days (68)
Last 365 days (1159)
2026 (86)
2025 (1187)
2024 (1386)
2023 (1589)
2022 (1661)
2021 (1627)
2020 (1369)
2019 (958)
2018 (731)
2017 (545)
2016 (319)
2015 (545)
2014 (6203)
2013 (341)
2012 (285)
2011 (336)
2010 (427)
Location
Africa (13)
Alabama (2)
Arizona (6)
Asia (1315)
Australia (138)
California (369)
Canada (105)
China (31)
Colorado (37)
Connecticut (12)
Delaware (12)
Europe (2705)
Florida (53)
Georgia (15)
Idaho (1)
Illinois (28)
India (7)
Indiana (38)
Japan (13)
Kansas (2)
Kentucky (2)
Louisiana (5)
Maine (8)
Maryland (42)
Massachusetts (266)
Michigan (18)
Minnesota (31)
Missouri (6)
Nevada (8)
New Hampshire (5)
New Jersey (136)
New York (166)
North Carolina (48)
Northern California (177)
Ohio (11)
Pennsylvania (108)
South America (33)
Southern California (163)
Tennessee (7)
Texas (56)
United States (1539)
Utah (24)
Virginia (7)
Washington D.C. (1)
Washington State (35)
West Virginia (1)
Wisconsin (4)
21,503 Results for "146".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Contego Medical Announces Unprecedented 30-day Outcomes From The PERFORMANCE III TCAR-IEP Study
146 Patients, 26 Sites — 0 Strokes, 0 Myocardial Infarctions, 0 Neurological Deaths
November 4, 2025
·
1 min read
Press Releases
Single-Use Bioprocessing Market to Worth USD 146.84 Billion by 2034
February 7, 2025
·
1 min read
Mergers & acquisitions
Q3 Saw Some of the Highest-Value Biopharma Acquisitions of the Year So Far
J&J still holds the top deal of the year by value with its $14.6 billion buy of Intra-Cellular in January, but the next four biggest acquisitions came in the past four months.
October 1, 2025
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
Johnson & Johnson Makes Major Neuro Play With $14.6B Intra-Cellular Buyout
Among Intra-Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for major depressive disorder.
January 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Medical Devices Market Size to Hit USD 1,146.95 Bn by 2034
December 16, 2024
·
1 min read
Earnings
J&J Says Deals Likely to Shrink After $14.6B Intra-Cellular Buy
On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus away from enormous takeovers to single-digit billion buy outs.
January 22, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Aires Announces Record Q3/2025 Revenue of $7.4 Million and 61% YoY Sales Growth and Discusses Factors Related to Liquidity and Continuing Operations
• Gross Profit increased 73% YoY • Gross Margin increased 500 basis points to 68% • Adjusted EBITDA loss reported at $1.46M vs $1.17M in year-ago quarter • Near-term business objectives are focused on preserving cash, stabilizing operations, and securing the financial resources required to support continuity of operations
November 26, 2025
·
16 min read
Press Releases
North America Active Pharmaceutical Ingredients (API) Market Size to Hit USD 146.39 Bn by 2033
June 12, 2024
·
18 min read
Depression
J&J Axes Late-Stage Depression Trial After Underwhelming Efficacy
Analysts do not believe the Phase III stumble for aticaprant will derail J&J’s broader neuroscience strategy, particularly given its recent $14.6 billion acquisition of Intra-Cellular Therapeutics and the success of Spravato for treatment-resistant depression.
March 7, 2025
·
2 min read
·
Tristan Manalac
Business
Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform
Under the collaboration and licensing agreement, Novo Nordisk and Neomorph are looking to discover, develop and commercialize novel molecular glue degraders for cardiometabolic and rare diseases.
February 27, 2024
·
2 min read
·
Tristan Manalac
1 of 2,151
Next
